Edible vaccine - The future for paediatric vaccines delivery?

Hugh Mason, Charles J. Arntzen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The need for multi-component vaccines that are inexpensive, orally delivered and stable might be met by using plants to express recombinant vaccine genes. Bacterial and viral diarrhoeal diseases are likely targets for such 'edible' vaccines, because their surface antigens are stable in the gut. Furthermore, antibodies secreted into the gut in response to antigen stimulation are well positioned to fight diarrhoeal infections. Animal studies show that such antibodies can be produced, and clinical studies will determine whether they can be produced in humans by similar means.

Original languageEnglish (US)
Pages (from-to)13-15
Number of pages3
JournalVaccines: Children and Practice
Volume1
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Edible Vaccines
Vaccines
Pediatrics
Synthetic Vaccines
Antibodies
Virus Diseases
Surface Antigens
Antigens
Infection
Genes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Edible vaccine - The future for paediatric vaccines delivery? / Mason, Hugh; Arntzen, Charles J.

In: Vaccines: Children and Practice, Vol. 1, No. 1, 1998, p. 13-15.

Research output: Contribution to journalArticle

@article{285f0d0c16da4321816560d30e2747b9,
title = "Edible vaccine - The future for paediatric vaccines delivery?",
abstract = "The need for multi-component vaccines that are inexpensive, orally delivered and stable might be met by using plants to express recombinant vaccine genes. Bacterial and viral diarrhoeal diseases are likely targets for such 'edible' vaccines, because their surface antigens are stable in the gut. Furthermore, antibodies secreted into the gut in response to antigen stimulation are well positioned to fight diarrhoeal infections. Animal studies show that such antibodies can be produced, and clinical studies will determine whether they can be produced in humans by similar means.",
author = "Hugh Mason and Arntzen, {Charles J.}",
year = "1998",
language = "English (US)",
volume = "1",
pages = "13--15",
journal = "Vaccines: Children and Practice",
issn = "1460-6887",
publisher = "Adis International Ltd",
number = "1",

}

TY - JOUR

T1 - Edible vaccine - The future for paediatric vaccines delivery?

AU - Mason, Hugh

AU - Arntzen, Charles J.

PY - 1998

Y1 - 1998

N2 - The need for multi-component vaccines that are inexpensive, orally delivered and stable might be met by using plants to express recombinant vaccine genes. Bacterial and viral diarrhoeal diseases are likely targets for such 'edible' vaccines, because their surface antigens are stable in the gut. Furthermore, antibodies secreted into the gut in response to antigen stimulation are well positioned to fight diarrhoeal infections. Animal studies show that such antibodies can be produced, and clinical studies will determine whether they can be produced in humans by similar means.

AB - The need for multi-component vaccines that are inexpensive, orally delivered and stable might be met by using plants to express recombinant vaccine genes. Bacterial and viral diarrhoeal diseases are likely targets for such 'edible' vaccines, because their surface antigens are stable in the gut. Furthermore, antibodies secreted into the gut in response to antigen stimulation are well positioned to fight diarrhoeal infections. Animal studies show that such antibodies can be produced, and clinical studies will determine whether they can be produced in humans by similar means.

UR - http://www.scopus.com/inward/record.url?scp=3142767481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142767481&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:3142767481

VL - 1

SP - 13

EP - 15

JO - Vaccines: Children and Practice

JF - Vaccines: Children and Practice

SN - 1460-6887

IS - 1

ER -